|
CAS号: | 872728-82-0 |
英文名称: | N-[4-(5-OXO-4,5-DIHYDRO-1,2,4-OXADIAZOL-3-YL)PHENYL]GLYCINE |
英文同义词: | N-[4-(2,5-Dihydro-5-oxo-1,2,4-oxadiazol-3-yl)phenyl]glycine;N-[4-(5-OXO-4,5-DIHYDRO-1,2,4-OXADIAZOL-3-YL)PHENYL]GLYCINE;Glycine,N-[4-(2,5-dihydro-5-oxo-1,2,4-oxadiazol-3-yl)phenyl]- |
中文名称: | N-[4-(2,5-二氢-5-氧代-1,2,4-恶二唑-3-基)苯基]甘氨酸 |
中文同义词: | N-[4-(2,5-二氢-5-氧代-1,2,4-恶二唑-3-基)苯基]甘氨酸;N-[4-(2,5-二氢-5-氧代-1,2,4-恶二唑-3-基)苯基]甘氨酸,抗血栓药 达比加群中间体 |
CBNumber: | CB51478573 |
分子式: | C10H9N3O4 |
分子量: | 0 |
MOL File: | 872728-82-0.mol |
|
|
|
|
N-[4-(2,5-二氢-5-氧代-1,2,4-恶二唑-3-基)苯基]甘氨酸化学性质 |
|
N-[4-(2,5-二氢-5-氧代-1,2,4-恶二唑-3-基)苯基]甘氨酸 性质、用途与生产工艺 |
|
N-[4-(2,5-二氢-5-氧代-1,2,4-恶二唑-3-基)苯基]甘氨酸 上下游产品信息 |
上游原料
|
下游产品
|
|
|
|
|
N-[4-(2,5-二氢-5-氧代-1,2,4-恶二唑-3-基)苯基]甘氨酸,抗血栓药 达比加群中间体
N-[4-(2,5-二氢-5-氧代-1,2,4-恶二唑-3-基)苯基]甘氨酸
872728-82-0
Glycine,N-[4-(2,5-dihydro-5-oxo-1,2,4-oxadiazol-3-yl)phenyl]-
N-[4-(2,5-Dihydro-5-oxo-1,2,4-oxadiazol-3-yl)phenyl]glycine
N-[4-(5-OXO-4,5-DIHYDRO-1,2,4-OXADIAZOL-3-YL)PHENYL]GLYCINE
|